Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis.

@article{Tektonidou2017SubclinicalAI,
  title={Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis.},
  author={Maria G. Tektonidou and Evrydiki Kravvariti and George D. Konstantonis and Nikolaos Tentolouris and Petros P. Sfikakis and Athanasios D. Protogerou},
  journal={Autoimmunity reviews},
  year={2017},
  volume={16 3},
  pages={308-312}
}
OBJECTIVE Although a high risk of subclinical atherosclerosis has been reported in Systemic Lupus Erythematosus (SLE), it is not adequately compared with that observed in other rheumatic and non-rheumatic high-cardiovascular (CVD) risk diseases, such as Rheumatoid Arthritis (RA) and Diabetes Mellitus (DM). Our objective was to evaluate the relative risk (RR) of subclinical atherosclerosis in SLE, RA and DM patients compared to healthy controls, and examine potential associations with… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS